BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32998739)

  • 1. Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes.
    Heo NJ; Rhee SY; Waalen J; Steinhubl S
    Cardiovasc Diabetol; 2020 Sep; 19(1):157. PubMed ID: 32998739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial.
    Steinhubl SR; Waalen J; Edwards AM; Ariniello LM; Mehta RR; Ebner GS; Carter C; Baca-Motes K; Felicione E; Sarich T; Topol EJ
    JAMA; 2018 Jul; 320(2):146-155. PubMed ID: 29998336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors.
    Sciacqua A; Perticone M; Tripepi G; Miceli S; Tassone EJ; Grillo N; Carullo G; Sesti G; Perticone F
    Int J Cardiol; 2014 Jul; 175(1):90-5. PubMed ID: 24836687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
    Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study.
    Gumprecht J; Lip GYH; Sokal A; Średniawa B; Mitręga K; Stokwiszewski J; Wierucki Ł; Rajca A; Rutkowski M; Zdrojewski T; Grodzicki T; Kaźmierczak J; Opolski G; Kalarus Z
    Cardiovasc Diabetol; 2021 Jun; 20(1):128. PubMed ID: 34167520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incident atrial fibrillation and risk of death in adults with chronic kidney disease.
    Bansal N; Fan D; Hsu CY; Ordonez JD; Go AS
    J Am Heart Assoc; 2014 Oct; 3(5):e001303. PubMed ID: 25332181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS).
    Steinhubl SR; Waalen J; Sanyal A; Edwards AM; Ariniello LM; Ebner GS; Baca-Motes K; Zambon RA; Sarich T; Topol EJ
    PLoS One; 2021; 16(10):e0258276. PubMed ID: 34610049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of atrial fibrillation in CKD and non-CKD populations: A cross-sectional analysis from the Kailuan study.
    Guo Y; Gao J; Ye P; Xing A; Wu Y; Wu S; Luo Y
    Int J Cardiol; 2019 Feb; 277():125-129. PubMed ID: 30473335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
    J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).
    Soliman EZ; Prineas RJ; Go AS; Xie D; Lash JP; Rahman M; Ojo A; Teal VL; Jensvold NG; Robinson NL; Dries DL; Bazzano L; Mohler ER; Wright JT; Feldman HI;
    Am Heart J; 2010 Jun; 159(6):1102-7. PubMed ID: 20569726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Ullal AJ; Kaiser DW; Fan J; Schmitt SK; Than CT; Winkelmayer WC; Heidenreich PA; Piccini JP; Perez MV; Wang PJ; Turakhia MP
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):39-48. PubMed ID: 27782345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
    Chao CT; Lee SY; Wang J; Chien KL; Hung KY
    Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.
    Lubitz SA; Faranesh AZ; Selvaggi C; Atlas SJ; McManus DD; Singer DE; Pagoto S; McConnell MV; Pantelopoulos A; Foulkes AS
    Circulation; 2022 Nov; 146(19):1415-1424. PubMed ID: 36148649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Function, Albuminuria, and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Ha JT; Freedman SB; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve SV
    Am J Kidney Dis; 2024 Mar; 83(3):350-359.e1. PubMed ID: 37777059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of metabolic syndrome and chronic kidney disease with atrial fibrillation: A nationwide population-based study in Korea.
    Choe WS; Choi EK; Han KD; Lee EJ; Lee SR; Cha MJ; Oh S
    Diabetes Res Clin Pract; 2019 Feb; 148():14-22. PubMed ID: 30578822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Chronic Kidney Disease With Atrial Fibrillation in the General Adult Population: A Nationwide Population-Based Study.
    Kim SM; Jeong Y; Kim YL; Kang M; Kang E; Ryu H; Kim Y; Han SS; Ahn C; Oh KH
    J Am Heart Assoc; 2023 Apr; 12(8):e028496. PubMed ID: 37066806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial Fibrillation and Risk of ESRD in Adults with CKD.
    Bansal N; Xie D; Tao K; Chen J; Deo R; Horwitz E; Hsu CY; Kallem RK; Keane MG; Lora CM; Raj D; Soliman EZ; Strauss L; Wolf M; Go AS;
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1189-1196. PubMed ID: 27073197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease predicts atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Șerban RC; Șuș I; Lakatos EK; Demjen Z; Ceamburu A; Fișcă PC; Somkereki C; Hadadi L; Scridon A
    Acta Cardiol; 2019 Dec; 74(6):472-479. PubMed ID: 30650039
    [No Abstract]   [Full Text] [Related]  

  • 19. Interatrial block, P terminal force or fragmented QRS do not predict new-onset atrial fibrillation in patients with severe chronic kidney disease.
    Hellman T; Hakamäki M; Lankinen R; Koivuviita N; Pärkkä J; Kallio P; Kiviniemi T; Airaksinen KEJ; Järvisalo MJ; Metsärinne K
    BMC Cardiovasc Disord; 2020 Oct; 20(1):437. PubMed ID: 33028216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR.
    Massicotte-Azarniouch D; Kuwornu JP; Carrero JJ; Lam NN; Molnar AO; Zimmerman D; McCallum MK; Garg AX; Sood MM
    Am J Kidney Dis; 2018 Feb; 71(2):191-199. PubMed ID: 29153994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.